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Abstract
Materials and methods In a pilot study, results of real-time
broad-range (16S rRNA) polymerase chain reaction (PCR)
performed on 45 blood samples of pediatric cancer patients
with fever and neutropenia were compared with blood
culture results.
Results The PCR assay used, having proven a high
sensitivity in artificially spiked blood samples, was positive
in only three of ten blood culture-positive samples, and it
was positive in 10 of 35 (29%) culture-negative samples.
Conclusion This broad-range PCR assay, which may
identify not-grown bacteria potentially contributing to
fever, needs improvement in sensitivity, and different
reasons for positive PCR in negative blood culture samples
need to be assessed before clinical application.
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Introduction
Blood cultures are the gold standard to diagnose bacteremia
since about a century. Their potential for further method-
ological improvement is negligible despite limitations in
speed of detection and sensitivity for slow-growing or
fastidious organisms or after start of antibacterial therapy
[6]. Broad-range polymerase chain reaction (PCR) might
offer a promising auxiliary diagnostic tool. It bases on
amplifying DNA regions coding for 16S or 23S rRNA
which is highly conserved in all bacteria [6, 7]. Subsequent
sequencing of amplicons allows for identification of
bacterial species [1, 6, 7].
In fever and neutropenia (FN) after chemotherapy,
bacteremia is potentially life threatening [8]. The sensitivity
and speed limitations of blood cultures are thus especially
important. The aim of this two-center pilot study was to
assess the applicability and potential problems of broad-
range PCR in the daily routine setting by comparing its
results with those of routine blood cultures in blood from
pediatric cancer patients with FN.
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Cancer patients aged 1 to 17 years presenting with fever
(axillary temperature greater than 38.0°C for more than 2 h,
or greater than 38.5°C once) and severe neutropenia
(absolute neutrophil count less than 0.5×109/l) induced by
nonmyeloablative chemotherapy were eligible. Besides oral
antiseptic rinsing, antimicrobial prophylaxis was restricted
to Pneumocystis jiroveci pneumonia prophylaxis by oral
cotrimoxazole or inhaled pentamidine. Multiple FN epi-
sodes per patient were allowed. Based on an estimated
proportion of 20% blood culture-positive samples [8], the
study aimed at ten blood culture positive episodes to
determine the proportion of blood culture-negative but
PCR-positive samples with a 95% confidence interval less
than 33% wide. Patients or their legal guardians gave
written informed consent. The respective cantonal ethics
committees approved the study.
Before starting empirical intravenous antimicrobial ther-
apy, blood was drawn into a syringe, from which two blood
culture bottles and a 5-ml K3E Vacutainer™ glass tube
(Becton Dickinson, Basel, Switzerland) for PCR analysis
were filled. Blood cultures were processed in routine
automated systems (BACTEC, Becton Dickinson, or
BacT/ALERT, bioMérieux, Geneva, Switzerland). The
Vacutainer™ tubes were transported without preprocessing
to the laboratory performing broad-range PCR.
Erythrocyte lysis, DNA extraction and real-time
broad-range PCR
Lysis of erythrocytes was performed upon receipt of the
sample in the laboratory as described [10], and the pellet
was stored at −80°C until further processing. The Wizard
SV genomic DNA purification system (Promega, Madison,
WI) augmented with lysozyme, lysostaphin, and proteinase
K, was used for DNA extraction as described [10], the final
elution volume being 200 μl.
Real-time broad-range PCR was performed on 2 μl DNA
elution to amplify a conserved DNA sequence encoding for
the 16S rRNA gene using forward primer Bak11W 5′-
AGTTTGATC(A/C)TGGCTCAG-3′, reverse primer Bak2
5′-GGACTAC(C/T/A)AGGGTATCTAAT-3′ [5], and probe
Tap 5′-CGTATTACCGCGGCTGCTGGCAC-3′ [9] with
TaqMan® Universal PCR Master Mix and No AmpErase®
UNG (Applied Biosystems, Chesire, UK) on an ABI PRISM
7700 Sequence Detector (Applied Biosystems) as described
[10]. Each PCR was performed in triplicate. When at least
two threshold cycle values were below 38 or one was below
34 [10], results were considered positive if sequencing of the
amplicon allowed for bacterial identification and considered
indeterminate if sequencing did not allow for identification.
Negative controls (blood from healthy volunteer) and
positive controls (blood spiked with 106 cfu Escherichia
coli per PCR) were determined in each run (Fig. 1).
The PCR assay using this specific combination of DNA
extraction and primer pair had proven to be the most
sensitive of nine assays tested. It detected 18 of 22 bacterial
species tested by spiking physiological saline at concen-
trations of 102 cfu per PCR or below [10]. Applying the
probe used together with this primer pair, the sensitivity to
detect E. coli was identical when spiking blood instead of
physiological saline [10].
Sequencing and bacterial identification
Amplicons were sequenced using primer Bak2 and the
BigDye Terminator v1.1 Cycle Sequencing Kit (Applied
Fig. 1 Real-time quantitative
broad-range PCR (TaqMan®)
for sample no. 12. The fluores-
cence (ΔRn), measured in each
PCR cycle for each sample, is
plotted on the y-axis against
cycle number on the x-axis for
the sample (# 12) in triplicate
and the positive (pos.; 106 cfu E.
coli per PCR) and negative
controls (neg.; blood from
healthy volunteer) each in
duplicate. The threshold cycle
(CT) value corresponds to the
cycle number where fluores-
cence exceeds the ΔRn thresh-
old set here at 7×10−3
(horizontal line)
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Biosystems). The samples were analyzed on an ABI
PRISM 310 Genetic Analyzer (PerkinElmer, Boston,
MA) as described [10]. Bacterial identification was done
in a two-step procedure as described [1, 10]. First, the
FASTA algorithm of the GCG Wisconsin software package
(Accelrys) with visual inspection of the electropherogram,
and sequence correction where necessary was performed. It
was followed by a second search using the basic local
alignment search tool (http://www.ncbi.nlm.nih.gov/blast).
Criteria for identification to the genus or species level were
used as described [1]. For each sequence, only the highest-
scoring and, if applicable, the next highest-scoring species
were recorded.
Statistics
StatXact 6.3.0 (Cytel, Cambridge, MA) was used for
Zelen’s exact test of homogeneity of odds ratios, and for
the exact Mann–Whitney test, where applicable.
Results
Blood cultures detected bacteremia in 10 (22%) of 45 FN
episodes in 31 patients with FN recruited consecutively in
two centers during a 6-month period in 2003. Patient’s
median age at first FN was 8.8 years (range, 1.4–16.5).
Table 1 Samples with positive blood cultures and/or positive or indeterminate broad-range PCR resultsa
Sample Blood culture Broad-range PCR, sequencing, and identification
Number Age (years) Result Sensitivityb Resultc Identification (score in bits, similarity)
1 8.8 Viridans streptococcus 10 Negative –
6 1.4 Escherichia coli 1 Negative –
10 8.9 Enterobacter cloacae 10,000 Negative –
Viridans streptococcus 10
12 2.7 CoNS 1 Positive Staphylococcus epidermidis (444, 96%)
15 13.5 CoNS 1 Negative –
Bacillus fragilis 100
16 13.5 B. fragilis 100 Indeterminate –
26 2.8 CoNS 1 Indeterminate –
27 15.6 CoNSc 1 Negative –
38 13.2 Klebsiella pneumoniaed 10,000 Positive Klebsiella pneumoniae (488, 92%)
41 3.0 K. pneumoniae 10,000 Positive Stenotrophomonas maltophilia (438, 91%)
Pseudomonas aeruginosa 100
2 1.7 Negative NA Positive Pseudomonas aerigompsa (82, 88%)
3 4.5 Negative NA Positive S. maltophilia (174, 84%)
9 6.7 Negative NA Positive Pseudomonas spp. (466, 92%)
S. maltophilia (462, 92%)
Acinetobacter calcinoaceticus (462, 92%)
18 2.8 Negative NA Indeterminate –
19 9.5 Negative NA Positive S. maltophilia (527, 94%)
A. calcinoaceticus (527, 94%)
20 13.0 Negative NA Indeterminate –
21 13.8 Negative NA Positive S. maltophilia (492, 93%)
23 4.1 Negative NA Positive S. maltophilia (206, 85%)
25 4.7 Negative NA Positive S. maltophilia (357, 89%)
30 3.1 Negative NA Positive S. maltophilia (258, 87%)
31 2.9 Negative NA Positive S. maltophilia (76, 87%)
40 3.8 Negative NA Positive S. maltophilia (145, 84%)
43 5.0 Negative NA Indeterminate –
44 4.9 Negative NA Indeterminate –
a In 21 episodes of fever and neutropenia, results of both methods were negative (median age at sampling, 11.2 years)
bAnalytical sensitivity (cfu per PCR) of this combination of DNA extraction and PCR for species detected in water [10]
c Positive, if at least two threshold cycle (CT) values below 38 or at least one CT value below 34 and bacterial identification possible by
sequencing the amplicon; indeterminate if at least two threshold cycle (CT) values below 38 or at least one CT value below 34 but no bacterial
identification by sequencing; negative in the remaining samples
dTwo different strains isolated
CoNS indicates coagulase-negative staphylococcus; NA not applicable, as blood cultures were negative
Support Care Cancer (2007) 15:637–641 639
Diagnoses included acute lymphoblastic leukemia in 14,
acute myeloid leukemia in two, lymphoma in five, and
solid tumors in ten patients.
Broad-range PCR, performed after optimization of the
method [10] in 2005, was positive in three and indetermi-
nate in two of ten blood culture-positive samples and
positive in 10 and indeterminate in 4 of 35 blood culture-
negative samples (Table 1). There were no significant
associations of these ratios with center, diagnostic group,
fever rule, and peripheral versus central venous access
(Zelen’s test; data not shown). Among patients with blood
culture-negative samples, a positive versus negative PCR
result was significantly associated with younger age
(median, 4.3 versus 11.2 years; Mann–Whitney statistic
394, p=0.013).
In the three samples with both positive blood culture and
PCR results, bacterial identification confirmed the species
detected in blood cultures in two samples (Staphylococcus
epidermidis and Klebsiella pneumoniae), whereas in the
third sample, growing K. pneumoniae and Pseudomonas
aeruginosa in blood cultures, Stenotrophomonas malto-
philia was identified.
In nine of the ten samples with negative blood culture
but positive PCR result, S. maltophilia with or without
other species (Acinetobacter calcoaceticus and Pseudomo-
nas spp.) was identified. The sequences of these nine
samples all differed from each other (data not shown).
Pseudomonas aerigompsa was identified in one sample.
Discussion
In contrast to the results of the study that had established
the specific assay of broad-range PCR used [10], the
sensitivity of real-time broad-spectrum PCR was not high
in this pilot study. Two main reasons might explain this.
First, the analytical sensitivity of the applied combination
of DNA extraction and PCR protocol ranges, depending on
the bacterial species, between 1 cfu and 10,000 per PCR in
physiological saline [10]. However, there was no evident
association between sensitivity and result of broad-range
PCR (Table 1). In contrast, the blood culture method may,
at least theoretically, detect bacteremia with only 1 cfu per
blood culture bottle for each species growing in this system.
Second, bacterial blood loads are expected to be lower after
nonmyeloablative than after myeloablative chemotherapy,
where sensitivity of broad-range PCR reported is higher [3,
6]. In the three PCR- and blood culture-positive samples,
species identification was correct in two samples, whereas
the apparent discrepancy in the third sample likely resulted
from the high agreement of 16S sequences of P. aeruginosa
grown in culture and S. maltophilia (formerly classified as
Pseudomonas maltophilia) identified by PCR.
Broad-range PCR was positive in 29% of the samples
with negative blood culture, which is comparable to
published results (up to 42%) [4, 6]. As broad-range PCR
aims at detection of additional cases of bacteremia
compared to blood cultures as the nonperfect gold standard,
this proportion cannot be converted into a specificity. In
nine of ten blood culture-negative but PCR-positive
samples, S. maltophilia was identified, twice together with
A. calcoaceticus and once with Pseudomonas spp, whereas
P. aerigompsa was identified once. These ubiquitous gram-
negative aerobe rods that can cause nosocomial infections
are known to grow well in routine blood culture systems.
Thus, it remains unclear to which entity the positive PCR
result in samples with negative blood culture correspond to.
First, they might represent contamination, an inherent
drawback in PCR-based methods [2, 6]. The fact that the
sequences of the nine samples with S. maltophilia identified
all differed from each other strongly argues against
laboratory contamination. Second, they might correspond
to clinically not relevant background bacterial DNA, i.e.,
residues of dead or degraded bacteria, reported in the blood
of healthy subjects [4, 6]. Background DNA of S.
maltophilia and Pseudomonas spp. has been described
[4]. Third, they might represent the clinically relevant
additional detection of bacterial infection, e.g., of bacterial
compounds spilled over from a localized infection into the
blood stream, not detected by blood culture. Another reason
for the failure to detect S. maltophilia in blood cultures
might have been the routine prophylactic application of oral
trimethoprim–sulfamethoxazole to prevent P. jiroveci pneu-
monia, as this antimicrobial shows activity against most
strains of S. maltophilia. In a different setting, namely, in
patients receiving intravenous antibacterial therapy, the
detection of Pseudomonas spp. and Acinetobacter spp. by
PCR in samples with negative blood cultures has been
described [3].
The statistically significant younger patient age in blood
culture-negative samples with positive versus negative PCR
might result from greater bacteremia in younger children, or
it might reflect younger children showing less containment
of local bacterial infections than older children. Thus, the
identification of bacteria in blood samples showing no
growth in cultures by broad-range PCR could help identify
neutropenic patients developing fever because of a bacterial
infection. Such information could assist in the devise of
empiric antimicrobial treatment in FN.
In conclusion, this pilot study demonstrates that real-
time broad-range PCR may be worth further studying in FN
because of its potential advantages over blood cultures
including faster detection and identification within one to
two working days [10], quantitative results allowing
longitudinal assessment and better sensitivity for slow-
growing or fastidious organisms, or after antimicrobial
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therapy [6]. Large prospective studies are needed to
optimize its performance and then to assess its final clinical
value. Less than optimal sensitivity, the inherent potential
for contamination, and the difficulty to distinguish back-
ground DNA from real bacteremia seem to be the main
drawbacks at this moment, with blood culture remaining as
the reference test. Possible optimizations are preincubation
in blood culture media to enhance sensitivity, nested PCR
to reduce the risk of contamination and to allow for
sequencing in infection with multiple germs [3], and the
simultaneous detection of DNA coding for 16S rRNA and
the corresponding rRNA itself as a measure of viability [6].
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